1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1.2.2 Analgesic & Pain Relievers 1.2.3 Dermatological Products 1.2.4 Cough, Cold, and Flu Products 1.2.5 Vitamin Supplements 1.2.6 Mineral Supplements 1.2.7 Ophthalmic Products 1.3 Market by Application 1.3.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Growth by Application: 2018 VS 2022 VS 2029 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.3.4 Online Pharmacy 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Perspective (2018-2029) 2.2 Over the Counter (OTC) Drugs & Dietary Supplements Growth Trends by Region 2.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Size by Region (2018-2023) 2.2.3 Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Region (2024-2029) 2.3 Over the Counter (OTC) Drugs & Dietary Supplements Market Dynamics 2.3.1 Over the Counter (OTC) Drugs & Dietary Supplements Industry Trends 2.3.2 Over the Counter (OTC) Drugs & Dietary Supplements Market Drivers 2.3.3 Over the Counter (OTC) Drugs & Dietary Supplements Market Challenges 2.3.4 Over the Counter (OTC) Drugs & Dietary Supplements Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Revenue 3.1.1 Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Revenue (2018-2023) 3.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Players (2018-2023) 3.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Over the Counter (OTC) Drugs & Dietary Supplements Revenue 3.4 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Concentration Ratio 3.4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Over the Counter (OTC) Drugs & Dietary Supplements Revenue in 2022 3.5 Over the Counter (OTC) Drugs & Dietary Supplements Key Players Head office and Area Served 3.6 Key Players Over the Counter (OTC) Drugs & Dietary Supplements Product Solution and Service 3.7 Date of Enter into Over the Counter (OTC) Drugs & Dietary Supplements Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Over the Counter (OTC) Drugs & Dietary Supplements Breakdown Data by Type 4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Size by Type (2018-2023) 4.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Type (2024-2029) 5 Over the Counter (OTC) Drugs & Dietary Supplements Breakdown Data by Application 5.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Size by Application (2018-2023) 5.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2018-2029) 6.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Growth Rate by Country: 2018 VS 2022 VS 2029 6.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2018-2023) 6.4 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2024-2029) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2018-2029) 7.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2018-2023) 7.4 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2024-2029) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2018-2029) 8.2 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Growth Rate by Region: 2018 VS 2022 VS 2029 8.3 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2018-2023) 8.4 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2024-2029) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2018-2029) 9.2 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2018-2023) 9.4 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2024-2029) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2018-2029) 10.2 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2018-2023) 10.4 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2024-2029) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 Pfizer Inc. 11.1.1 Pfizer Inc. Company Detail 11.1.2 Pfizer Inc. Business Overview 11.1.3 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction 11.1.4 Pfizer Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) 11.1.5 Pfizer Inc. Recent Development 11.2 Novartis International AG 11.2.1 Novartis International AG Company Detail 11.2.2 Novartis International AG Business Overview 11.2.3 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Introduction 11.2.4 Novartis International AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) 11.2.5 Novartis International AG Recent Development 11.3 Roche Holding AG 11.3.1 Roche Holding AG Company Detail 11.3.2 Roche Holding AG Business Overview 11.3.3 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Introduction 11.3.4 Roche Holding AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) 11.3.5 Roche Holding AG Recent Development 11.4 Merck & Co., Inc. 11.4.1 Merck & Co., Inc. Company Detail 11.4.2 Merck & Co., Inc. Business Overview 11.4.3 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction 11.4.4 Merck & Co., Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) 11.4.5 Merck & Co., Inc. Recent Development 11.5 Sanofi S.A 11.5.1 Sanofi S.A Company Detail 11.5.2 Sanofi S.A Business Overview 11.5.3 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Introduction 11.5.4 Sanofi S.A Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) 11.5.5 Sanofi S.A Recent Development 11.6 Johnson & Johnson 11.6.1 Johnson & Johnson Company Detail 11.6.2 Johnson & Johnson Business Overview 11.6.3 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Introduction 11.6.4 Johnson & Johnson Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) 11.6.5 Johnson & Johnson Recent Development 11.7 Gilead Sciences 11.7.1 Gilead Sciences Company Detail 11.7.2 Gilead Sciences Business Overview 11.7.3 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Introduction 11.7.4 Gilead Sciences Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) 11.7.5 Gilead Sciences Recent Development 11.8 GlaxoSmithKline plc. 11.8.1 GlaxoSmithKline plc. Company Detail 11.8.2 GlaxoSmithKline plc. Business Overview 11.8.3 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction 11.8.4 GlaxoSmithKline plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) 11.8.5 GlaxoSmithKline plc. Recent Development 11.9 Bayer Healthcare AG 11.9.1 Bayer Healthcare AG Company Detail 11.9.2 Bayer Healthcare AG Business Overview 11.9.3 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Introduction 11.9.4 Bayer Healthcare AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) 11.9.5 Bayer Healthcare AG Recent Development 11.10 AstraZeneca plc. 11.10.1 AstraZeneca plc. Company Detail 11.10.2 AstraZeneca plc. Business Overview 11.10.3 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction 11.10.4 AstraZeneca plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) 11.10.5 AstraZeneca plc. Recent Development 11.11 Alacer Corp. 11.11.1 Alacer Corp. Company Detail 11.11.2 Alacer Corp. Business Overview 11.11.3 Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Introduction 11.11.4 Alacer Corp. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) 11.11.5 Alacer Corp. Recent Development 11.12 Alcon Inc. 11.12.1 Alcon Inc. Company Detail 11.12.2 Alcon Inc. Business Overview 11.12.3 Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction 11.12.4 Alcon Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) 11.12.5 Alcon Inc. Recent Development 11.13 Alfresa Pharma Corporation 11.13.1 Alfresa Pharma Corporation Company Detail 11.13.2 Alfresa Pharma Corporation Business Overview 11.13.3 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Introduction 11.13.4 Alfresa Pharma Corporation Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) 11.13.5 Alfresa Pharma Corporation Recent Development 11.14 Alkalon A/S 11.14.1 Alkalon A/S Company Detail 11.14.2 Alkalon A/S Business Overview 11.14.3 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Introduction 11.14.4 Alkalon A/S Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) 11.14.5 Alkalon A/S Recent Development 11.15 Alliance Healthcare 11.15.1 Alliance Healthcare Company Detail 11.15.2 Alliance Healthcare Business Overview 11.15.3 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Introduction 11.15.4 Alliance Healthcare Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) 11.15.5 Alliance Healthcare Recent Development 11.16 Allergan, Plc. 11.16.1 Allergan, Plc. Company Detail 11.16.2 Allergan, Plc. Business Overview 11.16.3 Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction 11.16.4 Allergan, Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) 11.16.5 Allergan, Plc. Recent Development 11.17 Reckitt Benckiser Plc. 11.17.1 Reckitt Benckiser Plc. Company Detail 11.17.2 Reckitt Benckiser Plc. Business Overview 11.17.3 Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction 11.17.4 Reckitt Benckiser Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) 11.17.5 Reckitt Benckiser Plc. Recent Development 11.18 Bausch & Lomb 11.18.1 Bausch & Lomb Company Detail 11.18.2 Bausch & Lomb Business Overview 11.18.3 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Introduction 11.18.4 Bausch & Lomb Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) 11.18.5 Bausch & Lomb Recent Development 11.19 AbbVie Inc. 11.19.1 AbbVie Inc. Company Detail 11.19.2 AbbVie Inc. Business Overview 11.19.3 AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction 11.19.4 AbbVie Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) 11.19.5 AbbVie Inc. Recent Development 11.20 The Colgate-Palmolive Company 11.20.1 The Colgate-Palmolive Company Company Detail 11.20.2 The Colgate-Palmolive Company Business Overview 11.20.3 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Introduction 11.20.4 The Colgate-Palmolive Company Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) 11.20.5 The Colgate-Palmolive Company Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029 Table 2. Key Players of Analgesic & Pain Relievers Table 3. Key Players of Dermatological Products Table 4. Key Players of Cough, Cold, and Flu Products Table 5. Key Players of Vitamin Supplements Table 6. Key Players of Mineral Supplements Table 7. Key Players of Ophthalmic Products Table 8. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029 Table 9. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 10. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2018-2023) & (US$ Million) Table 11. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region (2018-2023) Table 12. Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Region (2024-2029) & (US$ Million) Table 13. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region (2024-2029) Table 14. Over the Counter (OTC) Drugs & Dietary Supplements Market Trends Table 15. Over the Counter (OTC) Drugs & Dietary Supplements Market Drivers Table 16. Over the Counter (OTC) Drugs & Dietary Supplements Market Challenges Table 17. Over the Counter (OTC) Drugs & Dietary Supplements Market Restraints Table 18. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Players (2018-2023) & (US$ Million) Table 19. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Players (2018-2023) Table 20. Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over the Counter (OTC) Drugs & Dietary Supplements as of 2022) Table 21. Ranking of Global Top Over the Counter (OTC) Drugs & Dietary Supplements Companies by Revenue (US$ Million) in 2022 Table 22. Global 5 Largest Players Market Share by Over the Counter (OTC) Drugs & Dietary Supplements Revenue (CR5 and HHI) & (2018-2023) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Over the Counter (OTC) Drugs & Dietary Supplements Product Solution and Service Table 25. Date of Enter into Over the Counter (OTC) Drugs & Dietary Supplements Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2018-2023) & (US$ Million) Table 28. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2018-2023) Table 29. Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Type (2024-2029) & (US$ Million) Table 30. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2024-2029) Table 31. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2018-2023) & (US$ Million) Table 32. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Application (2018-2023) Table 33. Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Application (2024-2029) & (US$ Million) Table 34. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Application (2024-2029) Table 35. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 36. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2018-2023) & (US$ Million) Table 37. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2024-2029) & (US$ Million) Table 38. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 39. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2018-2023) & (US$ Million) Table 40. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2024-2029) & (US$ Million) Table 41. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029 Table 42. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2018-2023) & (US$ Million) Table 43. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2024-2029) & (US$ Million) Table 44. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 45. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2018-2023) & (US$ Million) Table 46. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2024-2029) & (US$ Million) Table 47. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 48. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2018-2023) & (US$ Million) Table 49. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2024-2029) & (US$ Million) Table 50. Pfizer Inc. Company Detail Table 51. Pfizer Inc. Business Overview Table 52. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Table 53. Pfizer Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million) Table 54. Pfizer Inc. Recent Development Table 55. Novartis International AG Company Detail Table 56. Novartis International AG Business Overview Table 57. Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Product Table 58. Novartis International AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million) Table 59. Novartis International AG Recent Development Table 60. Roche Holding AG Company Detail Table 61. Roche Holding AG Business Overview Table 62. Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Product Table 63. Roche Holding AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million) Table 64. Roche Holding AG Recent Development Table 65. Merck & Co., Inc. Company Detail Table 66. Merck & Co., Inc. Business Overview Table 67. Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Table 68. Merck & Co., Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million) Table 69. Merck & Co., Inc. Recent Development Table 70. Sanofi S.A Company Detail Table 71. Sanofi S.A Business Overview Table 72. Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Product Table 73. Sanofi S.A Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million) Table 74. Sanofi S.A Recent Development Table 75. Johnson & Johnson Company Detail Table 76. Johnson & Johnson Business Overview Table 77. Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Product Table 78. Johnson & Johnson Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million) Table 79. Johnson & Johnson Recent Development Table 80. Gilead Sciences Company Detail Table 81. Gilead Sciences Business Overview Table 82. Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Product Table 83. Gilead Sciences Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million) Table 84. Gilead Sciences Recent Development Table 85. GlaxoSmithKline plc. Company Detail Table 86. GlaxoSmithKline plc. Business Overview Table 87. GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Table 88. GlaxoSmithKline plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million) Table 89. GlaxoSmithKline plc. Recent Development Table 90. Bayer Healthcare AG Company Detail Table 91. Bayer Healthcare AG Business Overview Table 92. Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Product Table 93. Bayer Healthcare AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million) Table 94. Bayer Healthcare AG Recent Development Table 95. AstraZeneca plc. Company Detail Table 96. AstraZeneca plc. Business Overview Table 97. AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Table 98. AstraZeneca plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million) Table 99. AstraZeneca plc. Recent Development Table 100. Alacer Corp. Company Detail Table 101. Alacer Corp. Business Overview Table 102. Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Product Table 103. Alacer Corp. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million) Table 104. Alacer Corp. Recent Development Table 105. Alcon Inc. Company Detail Table 106. Alcon Inc. Business Overview Table 107. Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Table 108. Alcon Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million) Table 109. Alcon Inc. Recent Development Table 110. Alfresa Pharma Corporation Company Detail Table 111. Alfresa Pharma Corporation Business Overview Table 112. Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Product Table 113. Alfresa Pharma Corporation Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million) Table 114. Alfresa Pharma Corporation Recent Development Table 115. Alkalon A/S Company Detail Table 116. Alkalon A/S Business Overview Table 117. Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Product Table 118. Alkalon A/S Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million) Table 119. Alkalon A/S Recent Development Table 120. Alliance Healthcare Company Detail Table 121. Alliance Healthcare Business Overview Table 122. Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Product Table 123. Alliance Healthcare Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million) Table 124. Alliance Healthcare Recent Development Table 125. Allergan, Plc. Company Detail Table 126. Allergan, Plc. Business Overview Table 127. Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Table 128. Allergan, Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million) Table 129. Allergan, Plc. Recent Development Table 130. Reckitt Benckiser Plc. Company Detail Table 131. Reckitt Benckiser Plc. Business Overview Table 132. Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Table 133. Reckitt Benckiser Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million) Table 134. Reckitt Benckiser Plc. Recent Development Table 135. Bausch & Lomb Company Detail Table 136. Bausch & Lomb Business Overview Table 137. Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Product Table 138. Bausch & Lomb Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million) Table 139. Bausch & Lomb Recent Development Table 140. AbbVie Inc. Company Detail Table 141. AbbVie Inc. Business Overview Table 142. AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Table 143. AbbVie Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million) Table 144. AbbVie Inc. Recent Development Table 145. The Colgate-Palmolive Company Company Detail Table 146. The Colgate-Palmolive Company Business Overview Table 147. The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Product Table 148. The Colgate-Palmolive Company Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million) Table 149. The Colgate-Palmolive Company Recent Development Table 150. Research Programs/Design for This Report Table 151. Key Data Information from Secondary Sources Table 152. Key Data Information from Primary Sources List of Figures Figure 1. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Comparison by Type (2023-2029) & (US$ Million) Figure 2. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type: 2022 VS 2029 Figure 3. Analgesic & Pain Relievers Features Figure 4. Dermatological Products Features Figure 5. Cough, Cold, and Flu Products Features Figure 6. Vitamin Supplements Features Figure 7. Mineral Supplements Features Figure 8. Ophthalmic Products Features Figure 9. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Comparison by Application (2023-2029) & (US$ Million) Figure 10. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application: 2022 VS 2029 Figure 11. Hospital Pharmacies Case Studies Figure 12. Retail Pharmacies Case Studies Figure 13. Online Pharmacy Case Studies Figure 14. Others Case Studies Figure 15. Over the Counter (OTC) Drugs & Dietary Supplements Report Years Considered Figure 16. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size (US$ Million), Year-over-Year: 2018-2029 Figure 17. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size, (US$ Million), 2018 VS 2022 VS 2029 Figure 18. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region: 2022 VS 2029 Figure 19. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Players in 2022 Figure 20. Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over the Counter (OTC) Drugs & Dietary Supplements as of 2022) Figure 21. The Top 10 and 5 Players Market Share by Over the Counter (OTC) Drugs & Dietary Supplements Revenue in 2022 Figure 22. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million) Figure 23. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2018-2029) Figure 24. United States Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million) Figure 25. Canada Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million) Figure 26. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million) Figure 27. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2018-2029) Figure 28. Germany Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million) Figure 29. France Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million) Figure 30. U.K. Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million) Figure 31. Italy Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million) Figure 32. Russia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million) Figure 33. Nordic Countries Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million) Figure 34. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million) Figure 35. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region (2018-2029) Figure 36. China Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million) Figure 37. Japan Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million) Figure 38. South Korea Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million) Figure 39. Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million) Figure 40. India Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million) Figure 41. Australia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million) Figure 42. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million) Figure 43. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2018-2029) Figure 44. Mexico Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million) Figure 45. Brazil Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million) Figure 46. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million) Figure 47. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2018-2029) Figure 48. Turkey Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million) Figure 49. Saudi Arabia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million) Figure 50. Pfizer Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) Figure 51. Novartis International AG Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) Figure 52. Roche Holding AG Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) Figure 53. Merck & Co., Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) Figure 54. Sanofi S.A Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) Figure 55. Johnson & Johnson Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) Figure 56. Gilead Sciences Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) Figure 57. GlaxoSmithKline plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) Figure 58. Bayer Healthcare AG Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) Figure 59. AstraZeneca plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) Figure 60. Alacer Corp. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) Figure 61. Alcon Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) Figure 62. Alfresa Pharma Corporation Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) Figure 63. Alkalon A/S Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) Figure 64. Alliance Healthcare Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) Figure 65. Allergan, Plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) Figure 66. Reckitt Benckiser Plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) Figure 67. Bausch & Lomb Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) Figure 68. AbbVie Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) Figure 69. The Colgate-Palmolive Company Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) Figure 70. Bottom-up and Top-down Approaches for This Report Figure 71. Data Triangulation Figure 72. Key Executives Interviewed

Pfizer Inc. Novartis International AG Roche Holding AG Merck & Co., Inc. Sanofi S.A Johnson & Johnson Gilead Sciences GlaxoSmithKline plc. Bayer Healthcare AG AstraZeneca plc. Alacer Corp. Alcon Inc. Alfresa Pharma Corporation Alkalon A/S Alliance Healthcare Allergan, Plc. Reckitt Benckiser Plc. Bausch & Lomb AbbVie Inc. The Colgate-Palmolive Company